Diabetes

Latest News


Wade M. Aubry, MD, associate clinical professor, University of California, San Francisco, continues discussions saying that comparative effectiveness research (CER) and the evolution of evidence-based medicine can facilitate innovations under the Affordable Care Act (ACA), especially with the inclusion of value-based insurance design (VBID).

In this video segment Dr. Huckfeldt discussed factors contributing to low levels of glycemic control. Patient, medication and physician factors can all effect medication adherence.

In her keynote address Anne Peters, MD, CDE, Director, Clinical Diabetes Program, University of Southern California, opened the meeting by defining what patient-centered care is. Providing care that is respectful of and responsive to individual patient preferences, needs, values, and ensuring that patients are involved in all clinical decisions, said Dr. Peters. She emphasizes the importance of looking to the needs of the individual patient and make decisions.